News | April 08, 2014

GE Healthcare Debuts Connected Cardiovascular Care at ACC 2014

New cardiology offerings aimed at safe, fast and accurate imaging and treatment of the heart

April 7, 2014 — GE Healthcare showcased a new suite of connected cardiovascular technologies, including several for advanced imaging and new software capabilities, at ACC 2014. New innovations included advances in molecular diagnostics, super-speed computed tomography (CT) scans, and patient-friendly electrocardiograms.
 
Life Sciences
GE Healthcare’s molecular imaging agent AdreView (Iobenguane I-123) is the only FDA-approved molecular imaging agent for scintigraphic assessment of sympathetic innervation of the heart that can be used to help identify adult patients with lower one and two year mortality risk. The heart is supplied with sympathetic nerves that control cardiac conduction. Increased sympathetic nerve activity depletes norepinephrine (NE) storage and can signal heart failure, which may lead to cardiac death. AdreView imaging helps assess NE levels via an external imaging gamma camera. Serious hypersensitivity reactions have been reported following AdreView administration. The most common adverse reactions in NDA clinical trials — dizziness, rash, pruritus, flushing, headache, and injection-site reactions — occurred in less than 1.3 percent of patients. 
 
Healthcare IT
With Centricity Cardio Enterprise solution, cardiologists have a single point of access to unified patient data, images and reports across multiple modalities with end-to-end configurable workflows. The solution helps enhance patient care and financial performance by providing full clinical access, improved productivity and revenue cycle efficiencies.
 
The Centricity Cardio Enterprise solution comprises Centricity Cardio Imaging and Centricity Cardio Workflow. Centricity Cardio Imaging is a Web-based cardiovascular PACS that provides access to diagnostic quality images from anywhere with an Internet connection to help enable fast, more informed decisions. It helps optimize patient care and revenue cycle efficiencies by empowering users to manage the entire cardiovascular department, including scheduling, procedural data monitoring, report generation, billing and inventory management. At ACC, GE Healthcare introduced an expanded Centricity Cardio Workflow offering, including a new invasive peripheral vascular module to help cardiologists assess, document and report on the patient’s peripheral vessels.
 
Computed Tomography
GE Healthcare’s 510(k)-pending Revolution CT delivers uncompromised image quality and clinical capabilities through the convergence of coverage, spatial and temporal resolution in one system. Revolution also enables comprehensive cardiac exams with anatomic and functional information in just one heartbeat, even in challenging patients with higher heart rates.
 
Interventional Cardiology
Brent Gordon, M.D., of Loma Linda University utilizes GE’s Innova 3D and Innova HeartVision technologies to confidently manage complex procedures. “The Innova 3D and Innova HeartVision technologies, as well as cardiac analysis tools allow me to quickly define and analyze the anatomy of interest and strategize my intervention with each patient’s unique anatomy in mind,” said Gordon. “With a single injection, I can feel extremely confident in my measurements, determine optimal gantry angles, and create a virtual model that assists me in real-time through my planned intervention.”
 
Electrophysiology
Catheter ablation of atrial fibrillation is becoming an increasingly utilized therapy. A Duke Heart Center study of periprocedural imaging in catheter ablation involving more than 11,000 ablations, suggests this procedure’s outcomes improve when combined with adjunct imaging like CT, MR or ultrasound. According to the Duke study, when imaging is paired with atrial fibrillation catheter ablation, patients are at a lower risk for strokes and repeat ablation rates decrease.
 
“We found significant variation in how physicians image patients before and during AF ablation,” said Jonathan Piccini, M.D., assistant professor of medicine at Duke University Medical Center. “The periprocedural imaging was associated with improved outcomes. These findings are hypothesis generating, but highlight the importance of imaging decisions in catheter ablation. Significant opportunities exist to streamline these imaging technologies and to test best practices via prospective studies of multimodality imaging.”
 
Ultrasound
GE Healthcare ultrasound’s Vivid Cardiovascular Ultrasound systems provide innovative tools designed to help improve workflow efficiency through simplified image acquisition, intuitive navigation and advanced, yet easy to use quantification. New technologies showcased included the XDclear technology, Polar Vision and Depth Illumination communication enhancements.
 
Diagnostic Cardiology
The new MAC 2000 Resting ECG System with the latest version of Marquette 12SL analysis helps avoid variations in care delivery by standardizing ECG information from the physician office through the hospital. The system provides proven diagnostic support enabling clinicians to make fast, accurate diagnoses. Its flexible connectivity solutions offer clinicians the data they need to help improve patient outcomes and streamline workflow throughout the continuum of cardiac care. 
 
The Muse ECG management system is now bi-directionally open to Non-GE electrocardiographs for improved care collaboration and asset management. Muse can now bridge a healthcare system’s ECG investments through bi-directional data sharing with both Non-GE and GE electrocardiographs. This solution offers comprehensive data access for clinicians by integrating ECG data from devices manufactured by vendors such as Philips, Mortara, Nihon Kohden, Edan, and Schiller in addition to GE.
 
The new app-driven Seer 1000 Holter Recorder from GE Healthcare utilizes innovative technology to establish patient and physician confidence right from the start. The Seer 1000 is a small, comfortable multi-channel digital Holter recorder paired with the Seer 1000 application for tablets, smartphones or Bluetooth enabled PCs. The system enables fast and accurate patient data entry, visual confirmation of lead placement and a clear view of waveform quality starting from initial hookup. The battery life indicator provides an assurance that battery life is adequate prior to beginning a test. One button operation makes it simple for patients to use, which may help reduce the number of repeat studies.
 
For more information: www.gehealthcare.com
 

Related Content

DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
ScImage and Invia Partnership Announced
News | Cardiac PACS| September 19, 2017
ScImage Inc. and Invia Imaging Solutions recently announced formation of a joint partnership at the American Society of...
CZT SPECT camera detectors offered by GE.

A display of CZT SPECT gamma camera detectors at RSNA 2016. These detectors are more sensitive than those used in older cameras, allowing for faster scans or lower radiation dose. 

Feature | Nuclear Imaging| September 19, 2017 | Dave Fornell
Cardiac nuclear myocardial perfusion imaging (MPI) has been a mature area of imaging for years, but has recently star
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Hitachi Supria True64 CT Receives FDA Clearance
Technology | Computed Tomography (CT)| September 15, 2017
Hitachi Healthcare Americas Inc. announced it has attained U.S. Food and Drug Administration (FDA) 510(k) clearance to...
Philips Launches CardioMD IV Cardiac SPECT Solution at ASNC 2017
Technology | SPECT Imaging| September 15, 2017
September 15, 2017 — Philips highlighted its newest solution for...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
Overlay Init